07:55:34 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Beskrivning

LandNorge
ListaOAX Equities
SektorHälsovård
IndustriMedicinteknik
Observe Medical är ett norskt bolag verksamma inom medicinteknik. Bolaget bedriver utveckling av tekniska instrument som används inom intensivvården. Produkterna säljs under olika varumärken och är särskilt specialiserade för urinmätning. Störst verksamhet återfinns inom den nordiska samt europeiska marknaden. Bolaget kom till som en avknoppning från Navamedic och har sitt huvudkontor i Oslo.

Kalender

2022-11-03 Kvartalsrapport 2022-Q3
2022-08-25 Kvartalsrapport 2022-Q2
2022-06-03 Ordinarie utdelning OBSRV 0.00 NOK
2022-06-03 Kvartalsrapport 2022-Q1
2022-06-03 Årsstämma 2022
2022-03-29 Bokslutskommuniké 2021
2022-02-04 Extra Bolagsstämma 2022
2021-11-03 Kvartalsrapport 2021-Q3
2021-08-20 Kvartalsrapport 2021-Q2
2021-05-25 Ordinarie utdelning OBSRV 0.00 NOK
2021-05-21 Årsstämma 2021
2021-05-12 Kvartalsrapport 2021-Q1
2021-02-23 Bokslutskommuniké 2020
2020-11-03 Kvartalsrapport 2020-Q3
2020-08-18 Kvartalsrapport 2020-Q2
2020-07-01 Ordinarie utdelning OBSRV 0.00 NOK
2020-06-30 Årsstämma 2020
2020-06-16 Extra Bolagsstämma 2020
2020-05-12 Kvartalsrapport 2020-Q1
2020-02-25 Bokslutskommuniké 2019
2022-03-08 11:25:12
Mandatory disclosure pursuant to section 4-2 of the Norwegian Securities Trading
Act by Ingerø Reiten Investment Company AS ("IRIC").

Reference is made to Observe Medical ASA's (the "Company") stock exchange
announcement on 8 March 2021 regarding the completion of the acquisition of Biim
Ultrasound AS and the board of directors' resolution to issues 8,171,913 new
shares in the Company as partial consideration to the sellers of Biim Ultrasound
AS (the "Consideration Shares").

Following the registration of the share capital increase pertaining to the
Consideration Shares with the Norwegian Register of Business Enterprises (Nw.
Foretaksregisteret) (the "NRBE"), the share capital of Observe Medical will be
NOK 13,907,830.56, divided into 53,491,656 shares, each with a nominal value of
NOK 0.26. The registration of the share capital increase pertaining to the
Consideration Shares with the NRBE is expected to take place on or about 9 March
2022. IRIC owns 9,653,680 shares in the Company. Following the issue of the
Consideration Shares upon registration of the share capital increase with the
NRBE, IRIC's shareholding in the Company will be reduced from 21.30% to 18.05%
of the issued and outstanding shares and votes in the Company, and IRIC will as
such fall below the notifiable threshold of 20 % pursuant to section 4-2 of the
Norwegian Securities Trading Act.